Biology Reference
In-Depth Information
Table 5.1 Recurrence of P. vivax Parasitaemia Following Treatment of P. falciparum Malaria with Artemether + Lumefantrine
Number
of Patients
Completing
Follow-up
Duration of
Follow-up
(days)
Number (%)
with Recurrent
P. vivax *
Number (%) with Recurrent
P. falciparum (PCR
Unadjusted)
Percentage of
Recurrences due to
P. vivax
Reference
Southeast Asia and Oceania
Thailand
McGready et al. (2008)
42
124
37 § (29.8)
43 (34.7)
46.3%
Hutagalung et al. (2005)
42
225
90 (40.0)
27 (12.0)
76.9%
Lefevre et al. (2001)
28
155
6 (3.9)
7 (4.5)
46.2%
van Vugt et al. (1999) #
28
90
11 (12.2)
13 (14.4)
45.8%
van Vugt et al. (1999) #
28-63
142
43
8
van Vugt et al. (1998)
63
248
83 (35.5)
61 (24.6)
57.6%
Papua New Guinea
Karunajeewa et al. (2008)
42
102
66 (64.9)
5 (4.9)
93.0%
Myanmar
Smithuis et al. (2010)
63
137
62 (45.3)
15 (11.0)
80.5%
Laos
Mayxay et al. (2004)
42
107
5 (4.7)
14 (13.1)
26.3%
Stohrer et al. (2004)
42
47
2 (4.1)
13 (26.5)
13.3%
Indonesia
Ratcliff et al. (2007)
42
219
67 (30.6)
29 (13.2)
69.8%
 
Search WWH ::




Custom Search